Histamine H2 Antagonism as Adjuvant Therapy in Treatment Resistant Schizophrenia
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate whether blockade of the histamine H2 receptors in
the brain will have any beneficial effect on the symptoms of subjects with schizophrenia.